Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Kura Oncology, Inc. (KURA) had Operating Cash Flow per Share of $-0.97 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$18.27M |
|
$-73.33M |
|
$0.26M |
|
$18.00M |
|
$97.08M |
|
$-78.81M |
|
$5.49M |
|
$-73.33M |
|
$-73.33M |
|
$-73.33M |
|
$-73.33M |
|
$-73.33M |
|
$-73.33M |
|
$-78.81M |
|
$-79.36M |
|
88.61M |
|
88.61M |
|
$-0.83 |
|
$-0.83 |
|
| Balance Sheet Financials | |
$623.78M |
|
$7.61M |
|
$28.77M |
|
$652.55M |
|
$101.50M |
|
$9.75M |
|
$443.17M |
|
$544.67M |
|
$107.88M |
|
$107.88M |
|
$107.88M |
|
88.76M |
|
| Cash Flow Statement Financials | |
$-85.85M |
|
$-24.23M |
|
$0.07M |
|
$149.10M |
|
$39.08M |
|
$-110.02M |
|
$8.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.15 |
|
-- |
|
-- |
|
0.08 |
|
0.09 |
|
98.57% |
|
-431.51% |
|
-431.51% |
|
-- |
|
-401.45% |
|
-401.49% |
|
$-85.98M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.31 |
|
1.95 |
|
46.06 |
|
-67.97% |
|
-67.97% |
|
-11.24% |
|
-62.34% |
|
$1.22 |
|
$-0.97 |
|
|
Operating Cash Flow per Share |
$-0.97 |